Biofrontera AG
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Biofrontera AG generated cash of -$2,849,000, which is more than the previous year. Cash used in financing activities reached the amount of $5,948,000 last year. Net change in cash is therefore $5,427,000.
Cash Flow
| 2011 | -4.67M | -291.2K | 4.82M |
|---|---|---|---|
| 2012 | -5.17M | -138.30K | 8.12M |
| 2013 | -7.66M | -322.94K | 7.55M |
| 2014 | -7.92M | 78.87K | 13.42M |
| 2015 | -9.71M | 17.02K | 5.15M |
| 2016 | -10.73M | -455.30K | 22.36M |
| 2017 | -13.11M | -375K | 9.45M |
| 2018 | -13.43M | -511K | 22.27M |
| 2019 | -32.89M | 21.05M | 3.45M |
| 2020 | -2.84M | 2.87M | 5.94M |
BFRA Cash Flow Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 11.11M | 19.45M | 11.08M | 15.12M | 3.95M | 8.50M | 2.93M | 3.36M | 553.57K | 692.14K |
Operating activities | ||||||||||
Net income | -13.02M | -7.64M | -8.87M | -16.10M | -10.57M | -11.20M | -10.72M | -8.06M | -4.11M | -4.64M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 5.33M | 3.15M | 754K | 884K | 830.77K | 811.68K | 811.00K | 742.13K | 643.29K | 361.82K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 1.51M | -673K | -1.83M | 63K | -729.50K | -585.57K | 269.42K | -326.63K | -209.17K | 0 |
Inventories | -1.02M | -148K | 368K | -86K | -2.11M | -140.12K | 191.67K | -372.94K | -789.56K | -300.63K |
Accounts payable | -2.57M | 596K | 185K | -1.01M | 1.04M | 75.98K | 254.33K | -36.27K | 46.67K | 178.33K |
Cash generated by operating activities | -2.84M | -32.89M | -13.43M | -13.11M | -10.73M | -9.71M | -7.92M | -7.66M | -5.17M | -4.67M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -774K | -1.85M | -513K | -397K | -484.53K | -180.30K | -164.08K | -341.98K | 0 | 0 |
Acquisitions Net | 3.54M | 22.81M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 2.87M | 21.05M | -511K | -375K | -455.30K | 17.02K | 78.87K | -322.94K | -138.30K | -291.2K |
Financing activities | ||||||||||
Common Stock Issued | 7.91M | 0 | 24M | 0 | 24.19M | 6.31M | 15.33M | 0 | 12.49M | 1.71M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.36M | 0 | -50K | 0 | -8.06M | 0 | -2.24M | 0 | -3.76M | 0 |
Cash used in financing activities | 5.94M | 3.45M | 22.27M | 9.45M | 22.36M | 5.15M | 13.42M | 7.55M | 8.12M | 4.82M |
Net Change In Cash | 5.42M | -8.33M | 8.36M | -4.04M | 11.16M | -4.55M | 5.57M | -432.65K | 2.81M | -138.56K |
Cash at end of period | 16.54M | 11.11M | 19.45M | 11.08M | 15.12M | 3.95M | 8.50M | 2.93M | 3.36M | 553.57K |
| Data source | Data source |